Automated Nucleic Acid Extraction Devices Market Report 2025

The automated nucleic acid extraction devices market size has grown rapidly in recent years. It will grow from $5.93 billion in 2024 to $6.63 billion in 2025 at a compound annual growth rate (CAGR) of 11.7%. The growth in the historic period can be attributed to increasing demand for molecular diagnostics, growing awareness of the benefits of automation, expansion of the pharmaceutical and biotechnology industries, government initiatives to promote molecular diagnostics, growing demand for molecular diagnostics.

The automated nucleic acid extraction devices market size is expected to see rapid growth in the next few years. It will grow to $11.31 billion in 2029 at a compound annual growth rate (CAGR) of 14.3%. The growth in the forecast period can be attributed to increased demand for personalized medicine, increasing demand for automation, increasing focus on precision medicine, increasing demand for point-of-care testing, integration with next-generation sequencing. Major trends in the forecast period include technological advancements, increasing demand for molecular diagnostics, miniaturization of automated systems, point-of-care testing, integration of artificial intelligence (AI) and data analytics.

The rising incidence of infectious diseases is anticipated to propel the growth of the automated nucleic acid extraction devices market in the future. Infectious diseases are disorders caused by pathogenic microorganisms, including bacteria, viruses, fungi, or parasites, which can be transmitted directly or indirectly between individuals or from animals to humans. The increase in infectious diseases, especially during global health crises like pandemics, amplifies the demand for diagnostic testing. Automated nucleic acid extraction devices are crucial for sample preparation in molecular diagnostics, aiding in the detection of viruses and bacteria. For example, in September 2023, GOV.UK, a UK-based public sector information site, reported a 7% rise in tuberculosis (TB) cases in England during the first half of 2023 compared to the same period in 2022, with notifications increasing from 2,251 to 2,408. Thus, the growing prevalence of infectious diseases is driving the expansion of the automated nucleic acid extraction devices market.

The rise in infectious diseases is anticipated to contribute to the expansion of the automated nucleic acid extraction devices market. Infectious diseases caused by various microorganisms have increased the demand for diagnostic testing, especially during global health crises such as pandemics. Automated nucleic acid extraction devices play a vital role in preparing samples for molecular diagnostics, aiding in the detection of viruses and bacteria. For instance, in Australia in 2021, over 471,000 cases of COVID-19 were reported, alongside 86,000 cases of chlamydia (a sexually transmitted infection) and 37,000 cases of campylobacter (a gastrointestinal illness), as per a report by the Australian Institute of Health and Welfare. This surge in infectious diseases further drives the growth of the automated nucleic acid extraction devices market.

Product innovation stands as a prominent trend in the automated nucleic acid extraction devices market. Major companies in this sector are introducing innovative products to maintain their market position. For example, in August 2022, Aurora Biomed launched the VERSA NAP Automated DNA Extraction Systems, designed to automate DNA and RNA extractions and related purification protocols. This system, capable of processing 1-96 samples simultaneously, ensures the isolation of pure, high-quality DNA or RNA, delivering reliable nucleic acid results using plate grippers and transporters.

Major players within the automated nucleic acid extraction devices market are actively innovating by introducing automated nucleic acid extraction workstations to cater to a broader customer base, drive sales, and boost revenue. These workstations are specialized automated systems designed for extracting nucleic acids, such as DNA and RNA, from biological samples. For instance, Jiangsu Bioperfectus Technologies Co. Ltd., a China-based in-vitro diagnostic products provider, introduced the SAW-48 and Cell Nucleic Acid Extraction Kit (Magnetic Bead Method) in April 2023. The SAW-48, an innovative in-vitro diagnostic medical device, integrates sample loading, nucleic acid purification, and PCR setup functions into a single instrument. This system efficiently processes up to 48 samples concurrently, significantly reducing the time required to obtain test results. Its streamlined process benefits the detection of sexually transmitted diseases (STDs) and human papillomavirus (HPV), enhancing efficiency and speed in these diagnostic procedures.

In January 2023, ALS Limited, an Australia-based analytical and testing services company, acquired Invitek Molecular GmbH from Nuvisan GmbH. This strategic acquisition aims to expand ALS Limited's diagnostic capabilities and service offerings. Leveraging Invitek Molecular GmbH's technical expertise and experience in automated DNA/RNA extraction and nucleic acid purification solutions, ALS seeks to provide comprehensive diagnostic solutions to its clients, reinforcing its position as a one-stop-shop solution provider. Invitek Molecular GmbH, based in Germany, specializes in manufacturing automated solutions for DNA/RNA extraction and nucleic acid purification.

Major companies operating in the automated nucleic acid extraction devices market include QIAGEN NV, PerkinElmer Inc., F. Hoffmann-La Roche AG, Die Analytik Jena GmbH, Thermo Fisher Scientific Inc., Accubiomed Co. Ltd., AutoGen Inc., Bioneer Corporation, Illumina Inc., Tecan Trading AG, Merck Co. & KGaA, Becton Dickinson and Company, DiaSorin Molecular LLC, BioTeke Corporation (Wuxi) Co. Ltd., Tianlong-Xi'an TianLong Science and Technology Co. Ltd., Jiangsu Bioperfectus Technologies Co. Ltd., Hangzhou Bloer Technology Co. Ltd., MGI Tech Co. Ltd., Aurora Biomed Inc., Promega Corporation, Hamilton Company, Tecan Group Ltd., Beckman CoulterInc., Bio-Rad Laboratories Inc., Zymo Research Corporation, Agilent Technologies Inc., Danaher Corporation, BioChain Institute Inc., Biomatrica Inc., Corbett Life Science Pty Ltd., Eppendorf AG, GE Healthcare Life Sciences, GenScript Biotech Corporation, Greiner Bio-One International GmbH, IntegenX Inc., LGC Biosearch Technologies, MicroGEM International Company, Norgen Biotek Corp.

North America was the largest region in the automated nucleic acid extraction devices market in 2024. The regions covered in the automated nucleic acid extraction devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the automated nucleic acid extraction devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Automated nucleic acid extraction devices are equipment used for major amplification processes such as isolation, purification, and concentration to detect specific pathogens in molecular diagnostic methods. These devices save time and labor compared to manually extracting nucleic acids from the same number of samples.

The main types of automated nucleic acid extraction devices include instruments, kits, and consumables. Instruments are measurement tools used by researchers and practitioners for the analysis and assessment of test and measurement equipment in various research and diagnostic applications. These devices, which are used in automated nucleic acid extraction, come in product types such as fully automated and semi-automated. End-users include hospitals, diagnostic centers, forensic laboratories, pharmaceutical and biotechnology companies, and academic research institutes.

The automated nucleic acid extraction devices market research report is one of a series of new reports that provides automated nucleic acid extraction devices market statistics, including automated nucleic acid extraction devices industry global market size, regional shares, competitors with an automated nucleic acid extraction devices market share, detailed automated nucleic acid extraction devices market segments, market trends and opportunities, and any further data you may need to thrive in the automated nucleic acid extraction devices industry. This automated nucleic acid extraction devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The automated nucleic acid extraction devices market consists of sales of deoxyribonucleic acid (DNA) extraction kits, ribonucleic acid (RNA) extraction kits and protein extraction kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.